Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

Conditions: Non-Hodgkin Lymphoma Refractory/ Relapsed Interventions: Biological: CD19 t-haNK Sponsors: ImmunityBio, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials